UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003910
Receipt number R000004415
Scientific Title Effects of epidural analgesia and peripheral nerve block on postoperative analgesia and early knee rehabilitation after total knee arthroplasty
Date of disclosure of the study information 2010/07/15
Last modified on 2018/03/25 17:40:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of epidural analgesia and peripheral nerve block on postoperative analgesia and early knee rehabilitation after total knee arthroplasty

Acronym

Effects of epidural analgesia and peripheral nerve block on postoperative analgesia and early knee rehabilitation after total knee arthroplasty

Scientific Title

Effects of epidural analgesia and peripheral nerve block on postoperative analgesia and early knee rehabilitation after total knee arthroplasty

Scientific Title:Acronym

Effects of epidural analgesia and peripheral nerve block on postoperative analgesia and early knee rehabilitation after total knee arthroplasty

Region

Japan


Condition

Condition

patients scheduled for elective unilateral total knee arthroplasty under general anesthesia

Classification by specialty

Orthopedics Anesthesiology Operative medicine
Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of the present study is to compare peripheral nerve block with epidural analgesia in terms of analgesic efficacy, reduction of side effect from pain management method, and early knee rehabilitation after unilateral total knee arthroplasty.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

Day of knee flexion achievement above 120 degrees

Key secondary outcomes

Efficacy of postoperative pain management(VAS evaluation),
Thigh and calf circumrefence,
Rate of side effect
Rehabilitation milestone(Ambulation with a cane, range of motion of operative knee)
Frequency of Additional analgesia


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

<Group CFNB(continuous femoral nerve block)>
Preoperative insertion of continuous femoral nerve block catheter and injection of 0.3% ropivacaine 60mg for continuous femoral nerve block and single-shot sciatic nerve block at the operative side (30mg ropivacaine respectively).
Postoperative continuous infusion of 0.15% ropivacaine 4mL/h for 60 hours.

Interventions/Control_2

<Group CEI(continuous epidural infusion)>
Preoperative insertion of epidural catheter at L3/4. Injection of 0.3% ropivacaine 90mg during surgery.
Postoperative continuous infusion of 0.15% ropivacaine 4mL/h for 60 hours.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients scheduled unilateral total knee arthroplasty at Osaka University Medical Hospital.

Key exclusion criteria

Inability to communicate lucidly.
Revision knee arthroplasty.
Chronic pain syndrome unrelated to knee pathology.
Allergy to local anesthetics.
ASA phisical status above III.
Chronic opioid use.
Severe diabetes mellitus with sensory disorder.
Neurologically-disabled.
Contraindications to epidural analgesia or peripheral nerve block.

Target sample size

66


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takaya Inoue

Organization

Osaka University Graduate School of Medicine

Division name

Department of Anesthesia and Intensive Care Medicine

Zip code


Address

2-2 Yamadaoka, Suita City, Osaka, Japan

TEL

06-6879-3133

Email

sakayline@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Norihiro Sakai

Organization

Osaka University Graduate School of Medicine

Division name

Department of Anesthesia and Intensive Care Medicine

Zip code


Address

2-2 Yamadaoka, Suita City, Osaka, Japan

TEL

06-6879-3133

Homepage URL


Email

sakayline@gmail.com


Sponsor or person

Institute

Department of Anesthesia and Intensive Care Medicine, Osaka University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2010 Year 07 Month 15 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

http://www.ncbi.nlm.nih.gov/pubmed/23434107

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2010 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2010 Year 07 Month 01 Day

Last follow-up date

2011 Year 07 Month 01 Day

Date of closure to data entry

2011 Year 07 Month 01 Day

Date trial data considered complete

2011 Year 08 Month 01 Day

Date analysis concluded

2011 Year 10 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 07 Month 13 Day

Last modified on

2018 Year 03 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004415


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name